Gabapentin, pregabalin, baclofen recent warnings

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org

1 post / 0 new
Jacqueline Kao
Jacqueline Kao's picture
Offline
Last seen: 3 years 1 week ago
Joined: 06/05/2018 - 11:46
Gabapentin, pregabalin, baclofen recent warnings

Hello,
The FDA recently released a Medwatch alert on serious breathing problems for patients taking gabapentin or pregabalin and other CNS depressants. Also there's been more articles regarding misuse of gabapentin and baclofen (https://www.tandfonline.com/doi/pdf/10.1080/15563650.2019.1687902?needAc...), especially with the initiatives to reduce opioid use and increase use of other pain medications.

With that in mind, have any institutions made any changes or restrictions to the use of gabapentin and the other medications listed? We were considering maybe adding a new drug-disease interaction alert, but this would likely not change practice significantly and probably be overridden.

Thanks!